Logo

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Share this

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Shots:

  • TScan signs exclusive research and option to license agreement with Qiagen to develop T cell-based laboratory tests for detecting prior exposure to the SARS-CoV-2
  • Qiagen gets an option to license the rights and IP for several of TScan discovered immunodominant T cell targets- associated sequences and relevant data for the development and commercialization of IVD tests. In advance of exercising its option- Qiagen has the right to evaluate TScan’s discoveries
  • The targeted immunodominant were identified through the T-Scan TCR/Target discovery platform enabling the mapping of the specific epitopes in SARS-CoV-2

­  Ref: Businesswire | Image: TrialSite News

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions